Menu
Skip to content

Interventional Radiology

Interventional Radiology

The working group focuses on the subject area of ​​interventional radiological procedures. Projects regarding outcome and the technical optimization of interventional procedures (both vascular interventions and interventional oncological therapies) are dealt with. In addition, the effectiveness of innovative interventional therapies are assessed. The main focus of the working group is the clinical impact of interventional radiological procedures.

Transjugular portosystemic shunt

Technical optimization, analysis of impact on metabolism and liver architecture.

Vascular interventions

Investigation of the clinical success of vascular interventions to improve blood circulation for the arterial and venous system (stents, catheter fragmentation).

Tumor-Therapy

Examination of the outcome after loco-regional tumor therapies (TACE, radio frequency, microwave ablation) and after selective intra-arterial radio embolization.

Device-Research

Investigation of new interventional methods / material.

Group Leader

PD Dr. med. Daniel Kütting
Tel.: +49 228 287 19820
E-Mail: Enable JavaScript to view protected content.

Dr. med. Carsten Meyer
Tel.: +49 228 287 15762
E-Mail: Enable JavaScript to view protected content.

Unsere Webseite verwendet Cookies.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Unsere Webseite verwendet Cookies.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.

Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

Sehr geehrte Damen und Herren,

gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung: Enable JavaScript to view protected content.

Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.